These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 15547097

  • 1. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Kasapçopur O, Altun S, Aslan M, Karaarslan S, Kamburoglu-Göksel A, Saribas S, Arisoy N, Kocazeybek B.
    Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097
    [Abstract] [Full Text] [Related]

  • 2. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [Abstract] [Full Text] [Related]

  • 3. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Habib HM, Mosaad YM, Youssef HM.
    Immunol Invest; 2008 Sep; 37(8):849-57. PubMed ID: 18991100
    [Abstract] [Full Text] [Related]

  • 4. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
    van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B, Dijkmans B, van Venrooij WJ.
    J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206
    [Abstract] [Full Text] [Related]

  • 5. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.
    Ferucci ED, Majka DS, Parrish LA, Moroldo MB, Ryan M, Passo M, Thompson SD, Deane KD, Rewers M, Arend WP, Glass DN, Norris JM, Holers VM.
    Arthritis Rheum; 2005 Jan; 52(1):239-46. PubMed ID: 15641089
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 7. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
    Dewint P, Hoffman IE, Rogge S, Joos R, Union A, Dehoorne J, Delanghe J, Veys EM, De Keyser F, Elewaut D.
    Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
    [Abstract] [Full Text] [Related]

  • 8. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 9. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 10. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF, Zhang QB, Zhou JG, Yuan GH, Wei J, Xing Y, Liu JP, Jiang L, Chen JP.
    Lupus; 2009 Jul 15; 18(8):713-7. PubMed ID: 19502267
    [Abstract] [Full Text] [Related]

  • 11. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
    J Rheumatol; 2009 Apr 15; 36(4):712-6. PubMed ID: 19286846
    [Abstract] [Full Text] [Related]

  • 12. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct 15; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 13. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z.
    Isr Med Assoc J; 2008 Jan 15; 10(1):32-6. PubMed ID: 18300568
    [Abstract] [Full Text] [Related]

  • 14. Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis.
    Skare TS, Nisihara RM, Silva RM, Munhoz da Silva DJ, Gameiro Silva MB, Utiyama SR.
    J Clin Rheumatol; 2011 Dec 15; 17(8):421-3. PubMed ID: 22089992
    [Abstract] [Full Text] [Related]

  • 15. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
    Lipinska J, Lipinska S, Kasielski M, Smolewska E.
    Clin Rheumatol; 2016 Nov 15; 35(11):2699-2706. PubMed ID: 27457366
    [Abstract] [Full Text] [Related]

  • 16. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
    Korkmaz C, Us T, Kaşifoğlu T, Akgün Y.
    Clin Biochem; 2006 Oct 15; 39(10):961-5. PubMed ID: 16979149
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M, Miu N, Bolba C, Iancu M, Spârchez Z, Rednic S.
    Clin Rheumatol; 2016 Mar 15; 35(3):601-7. PubMed ID: 25994613
    [Abstract] [Full Text] [Related]

  • 18. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC.
    Arthritis Rheum; 2007 May 15; 56(5):1454-63. PubMed ID: 17469103
    [Abstract] [Full Text] [Related]

  • 19. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
    Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N.
    Rheumatology (Oxford); 2005 Aug 15; 44(8):1056-60. PubMed ID: 15901902
    [Abstract] [Full Text] [Related]

  • 20. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.
    Sihvonen S, Korpela M, Mustila A, Mustonen J.
    J Rheumatol; 2005 Nov 15; 32(11):2089-94. PubMed ID: 16265684
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.